Product fact sheet
MitoADAPT MID 4.0: Technical Specifications & Pending Lab Status
Source-backed MitoADAPT MID 4.0 hardware facts, eight-wavelength architecture, controls, electrical specifications, and its still-pending LightLab test status.
A mid-size eight-wavelength, mode-selectable MitoADAPT panel with current manufacturer specifications; Mito's independent-test index still lists its LightLab test data as pending.
buyers comparing mode-selectable mid-size panel hardware, buyers who want explicit visibility into pending third-party testing
comparisons that require completed accredited radiometric measurements, anyone treating manufacturer irradiance as equivalent to the completed LightLab reports
Key tradeoff: The physical and control specifications are well documented, but the current independent-test record explicitly says no LightLab test data are available yet.
This is a factual fit-and-tradeoff summary, not a product recommendation. Formula, device and brand claims remain manufacturer claims unless the cited source is explicitly regulatory or independent testing.
The MitoADAPT MID 4.0 is the mid-size panel in Mito Red Light’s eight-wavelength MitoADAPT family. The current manufacturer comparison table documents its dimensions, weight, LED architecture, published electrical consumption, and the family’s eleven selectable wavelength combinations.
The independent test is still pending
Mito’s current independent-test index explicitly lists the MitoADAPT MID 4.0 as “No test data yet · pending LightLab.” That means Homeapotherapy does not populate independent wall draw, radiant power, average irradiance, or peak irradiance fields for this model yet.
The manufacturer publishes its own irradiance figures, but those are not substituted into the normalized LightLab fields simply because a number exists. The site waits for the completed test when the comparison field is defined around a completed accredited-lab protocol.
Current manufacturer-documented hardware
The current comparison table lists a 12 × 27 inch panel-only footprint, 19 lb weight, 216 lenses / 432 chips, and 310 W published power consumption. The MitoADAPT family uses published peaks at 590, 630, 660, 670, 810, 830, 850, and 940 nm with eleven selectable wavelength combinations.
What remains unknown
Until the pending LightLab work is published, there is no normalized third-party wall draw, total radiant power, spatial-average irradiance, or peak irradiance in the Homeapotherapy record. Homeapotherapy has also not hands-on tested the device.
For help interpreting those measurement categories, see How to Read Red Light Device Specifications.
Technical specifications
Published specs and what they mean
Physical
- Panel dimensions
- 12 × 27 in (W × H; panel only) Basis: Manufacturer published Current manufacturer comparison table. Source: MitoADAPT 4.0 Red Light Therapy Panel Series
- Weight
- 19 lb Basis: Manufacturer published Current manufacturer comparison table. Source: MitoADAPT 4.0 Red Light Therapy Panel Series
Optical
- Published wavelengths
- 590 / 630 / 660 / 670 / 810 / 830 / 850 / 940 nm Basis: Manufacturer published Current manufacturer specification. Source: MitoADAPT 4.0 Red Light Therapy Panel Series
- LED architecture
- 216 lenses / 432 chips Basis: Manufacturer published Current manufacturer comparison table. Source: MitoADAPT 4.0 Red Light Therapy Panel Series
Electrical
- Published power consumption
- 310 W Basis: Manufacturer published Current manufacturer comparison table; not an independent wall-draw measurement. Source: MitoADAPT 4.0 Red Light Therapy Panel Series
Controls
- Running modes
- 11 selectable wavelength combinations Basis: Manufacturer published Manufacturer describes eleven mode-selectable wavelength combinations. Source: MitoADAPT 4.0 Red Light Therapy Panel Series
What the current record does not establish
- Mito's independent-test index states: No test data yet · pending LightLab.
- No normalized independent wall draw, radiant power, average irradiance or peak irradiance is recorded until that test is published.
- Homeapotherapy has not independently tested the device.
A missing field is not evidence that the device lacks the feature or performs poorly. It means we do not currently have a sufficiently comparable, sourced value in the normalized record.
Source labels preserve provenance. Manufacturer specifications, ingredient lists and performance claims are not treated as independent clinical evidence; regulatory records and independent measurements are identified separately when available.
Dose and irradiance context
What the output number means over time
Fluence is a calculation, not a treatment recommendation. For continuous output, fluence in J/cm² equals irradiance in mW/cm² × seconds ÷ 1000. The calculation only remains meaningful at the measurement conditions used for the irradiance value.
No comparable independent average irradiance is normalized
This device may have a manufacturer-published irradiance claim, but Homeapotherapy does not calculate time-to-fluence from that number unless the current record contains a sufficiently defined independent area-average measurement. This avoids presenting unlike measurement methods as interchangeable.
What this calculation still cannot tell you
- whether this is an effective dose for any condition;
- how irradiance changes at a different distance or across curved anatomy;
- how much energy reaches tissue below the surface;
- whether a study used the same wavelength distribution, spot size, pulse mode or treatment schedule;
- whether peak irradiance would produce the same area exposure as the average value shown here.
Read Red Light Irradiance, Fluence and Dose Explained before trying to compare this output with a clinical paper or another panel.
Clinical evidence context
Where these wavelengths overlap with human research
Published device wavelengths: 590 / 630 / 660 / 670 / 810 / 830 / 850 / 940 nm.
This is a hardware-to-literature cross-reference, not a claim that this product treats any condition. A matching nominal wavelength does not reproduce a study's irradiance, dose, distance, treatment area, emitter geometry, schedule or patient population.
Research areas worth checking
- Pattern hair loss — human studies commonly use visible-red wavelengths, especially around the mid-600 nm range.
- Acne and inflammatory skin — red-light protocols exist, but acne studies may also use blue light and should not be generalized from panel specs.
- Skin rejuvenation and photoaging — visible-red and red/NIR LED protocols have been studied with varied devices and endpoints.
- Knee osteoarthritis — near-infrared wavelengths appear in the clinical literature, but wavelength alone does not establish an equivalent treatment protocol.
- Muscle recovery and musculoskeletal pain — research spans red and near-infrared bands with substantial protocol variation.
- Transcranial PBM and cognition — some research uses near-infrared wavelengths, but a body panel is not automatically equivalent to a head-targeted transcranial device.
- See the full wavelength-by-condition evidence chart for evidence strength, treatment geometry and major caveats.
Do not infer from wavelength overlap
- that this device is clinically proven for the linked condition;
- that more wavelengths are better;
- that the highest published irradiance is the best dose;
- that an open wound should be treated with a consumer device without appropriate wound assessment.
For wounds specifically, start with the wound-care safety decision guide before interpreting any device specification.
Safety first
What should make you slow down?
Use the product as directed, avoid treating concentrated wellness products as automatically harmless, and ask a qualified clinician when your situation or medication use makes the decision less routine.
Where to buy
Current tracked merchants
Commerce note: merchant economics never enter our editorial score. Affiliate links are identified as (paid link) and use sponsored-link markup.
No merchant destination is currently tracked for this product.
Source trail
Primary documents and supporting evidence
- MitoADAPT 4.0 Red Light Therapy Panel SeriesMito Red Light · Manufacturer · retrieved 2026-08-11
- Independent ISO/IEC 17025 Panel Test DataMito Red Light / LightLab International · Independent lab · HTML data index · retrieved 2026-08-11
- Product Manuals & VideosMito Red Light · Manufacturer manual · Manual index · retrieved 2026-08-11